

Novartis AG
(NYSE:NVS)
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
top performing NVS trades

Daniel Goldman
House (D-NY)
24.90%

Sheldon Whitehouse
Senate (D-RI)
20.00%

Thomas R. Carper
Senate (D-DE)
19.30%
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Novartis trades made by congress members.
![]() George WhitesidesHouse (D-CA) | $100K - $250K | stock | Sale | Apr 23, 2025 | Mar 24, 2025 | House |
![]() Sheldon WhitehouseSenate (D-RI) | $1K - $15K | stock | Sale (Partial) | May 20, 2024 | Apr 09, 2024 | Senate |
![]() Sheldon WhitehouseSenate (D-RI) | $15K - $50K | stock | Purchase | Oct 17, 2023 | Sep 20, 2023 | Senate |
![]() Daniel GoldmanHouse (D-NY) | $50K - $100K | stock | Sale | Aug 13, 2023 | Jul 10, 2023 | House |
![]() Thomas R. CarperSenate (D-DE) | $1K - $15K | stock | Purchase | May 01, 2023 | Apr 26, 2023 | Senate |
![]() Daniel GoldmanHouse (D-NY) | $50K - $100K | stock | Purchase | Apr 17, 2023 | Mar 31, 2023 | House |
![]() Daniel GoldmanHouse (D-NY) | $15K - $50K | stock | Sale (Partial) | Mar 20, 2023 | Feb 27, 2023 | House |
![]() Kevin HernHouse (R-OK) | $1K - $15K | stock | Sale | Feb 14, 2023 | Jan 31, 2023 | House |